Keytruda for immunotherappy cancer treatment for lung cancer

Keytruda for immunotherappy cancer treatment for lung cancer

Keytruda Lung Cancer Commercial

Scientists have made a huge discovery in immunotherapy cancer treatments. The drug Keytruda was approved by the FDA. Keytruda is an immunotherapy drug that can help patients with metastatic non-small-cell lung cancer use their own immune system to stop the cancer from growing. If effective for the patient, Keytruda would replace chemotherapy. Dr. Philip Greenberg, head of immunology at the Fred Hutchinson Cancer Research Center in Seattle, stated, “It’s certainly going to become an independent way of treating cancers.”